134 related articles for article (PubMed ID: 38506538)
1. Direct Quantification of Gadolinium Retention in Young Patients by ICP-MS Analysis of Extracted Teeth.
O'Donohue LS; Friedland MH; Shankar PR; Gonzalez-Cabezas C; Flannagan SE; Aronovich S; Masotti M; Bornschein RE; Davenport MS
AJR Am J Roentgenol; 2024 Mar; ():. PubMed ID: 38506538
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
[TBL] [Abstract][Full Text] [Related]
3. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
[TBL] [Abstract][Full Text] [Related]
4. Observed Deposition of Gadolinium in Bone Using a New Noninvasive in Vivo Biomedical Device: Results of a Small Pilot Feasibility Study.
Lord ML; Chettle DR; Gräfe JL; Noseworthy MD; McNeill FE
Radiology; 2018 Apr; 287(1):96-103. PubMed ID: 29237148
[TBL] [Abstract][Full Text] [Related]
5. Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents.
Duncan BR; Hasegawa M; Marshall DA; Gonzalez-Cuyar LF; Paulsen M; Kobayashi M; Maravilla KR; Simpson CD
Anal Bioanal Chem; 2021 Mar; 413(6):1571-1582. PubMed ID: 33506336
[TBL] [Abstract][Full Text] [Related]
6. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
[TBL] [Abstract][Full Text] [Related]
7. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
8. Spatially resolved quantification of gadolinium deposited in the brain of a patient treated with gadolinium-based contrast agents.
Fingerhut S; Niehoff AC; Sperling M; Jeibmann A; Paulus W; Niederstadt T; Allkemper T; Heindel W; Holling M; Karst U
J Trace Elem Med Biol; 2018 Jan; 45():125-130. PubMed ID: 29173468
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-based contrast agent attenuation does not impact PET quantification in simultaneous dynamic contrast enhanced breast PET/MR.
Allen TJ; Henze Bancroft LC; Kumar M; Bradshaw TJ; Strigel RM; McMillan AB; Fowler AM
Med Phys; 2022 Aug; 49(8):5206-5215. PubMed ID: 35621727
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: an autopsy study.
Fingerhut S; Sperling M; Holling M; Niederstadt T; Allkemper T; Radbruch A; Heindel W; Paulus W; Jeibmann A; Karst U
Acta Neuropathol; 2018 Jul; 136(1):127-138. PubMed ID: 29748901
[TBL] [Abstract][Full Text] [Related]
12. Mild Dissolution/Recomplexation Strategy for Speciation Analysis of Gadolinium from MR Contrast Agents in Bone Tissues by Means of HPLC-ICP-MS.
Schlatt L; Köhrer A; Factor C; Robert P; Rasschaert M; Sperling M; Karst U
Anal Chem; 2021 Aug; 93(33):11398-11405. PubMed ID: 34387072
[TBL] [Abstract][Full Text] [Related]
13. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
14. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events Associated with Intra-Arterial Administration of Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis.
MacLeod CA; Gauthier I; Davenport MS; McGrath TA; Khan F; Dos Santos MP; McInnes MDF; Schieda N
J Vasc Interv Radiol; 2023 Apr; 34(4):568-577.e10. PubMed ID: 36464013
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
Delfino R; Biasotto M; Candido R; Altissimo M; Stebel M; Salomè M; van Elteren JT; Vogel Mikuš K; Zennaro C; Šala M; Addobbati R; Tromba G; Pascolo L
Toxicol Lett; 2019 Feb; 301():157-167. PubMed ID: 30476537
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.
McDonald RJ; Levine D; Weinreb J; Kanal E; Davenport MS; Ellis JH; Jacobs PM; Lenkinski RE; Maravilla KR; Prince MR; Rowley HA; Tweedle MF; Kressel HY
Radiology; 2018 Nov; 289(2):517-534. PubMed ID: 30204075
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
[TBL] [Abstract][Full Text] [Related]
19. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
Pietsch H; Lengsfeld P; Steger-Hartmann T; Löwe A; Frenzel T; Hütter J; Sieber MA
Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
[TBL] [Abstract][Full Text] [Related]
20. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
